Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Raw Materials: 2020-2025

Historic Raw Materials for Puma Biotechnology (PBYI) over the last 4 years, with Sep 2025 value amounting to $3.6 million.

  • Puma Biotechnology's Raw Materials rose 1626.07% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 1626.07%. This contributed to the annual value of $7.2 million for FY2024, which is 26.17% up from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's Raw Materials is $3.6 million, which was down 43.97% from $6.5 million recorded in Q2 2025.
  • Puma Biotechnology's 5-year Raw Materials high stood at $7.2 million for Q4 2024, and its period low was $211,000 during Q3 2024.
  • For the 3-year period, Puma Biotechnology's Raw Materials averaged around $3.8 million, with its median value being $3.8 million (2023).
  • Per our database at Business Quant, Puma Biotechnology's Raw Materials crashed by 83.74% in 2024 and then surged by 1,626.07% in 2025.
  • Puma Biotechnology's Raw Materials (Quarterly) stood at $4.6 million in 2021, then slumped by 63.25% to $1.7 million in 2022, then skyrocketed by 239.07% to $5.7 million in 2023, then grew by 26.17% to $7.2 million in 2024, then surged by 1,626.07% to $3.6 million in 2025.
  • Its Raw Materials was $3.6 million in Q3 2025, compared to $6.5 million in Q2 2025 and $7.1 million in Q1 2025.